Lichenification occurs when repeated scratching or rubbing causes skin to thicken and become leathery. Certain skincare and ...

The following is a summary of “Dupilumab Improves Urticaria-Specific Quality of Life in Patients with Chronic Spontaneous ...

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

A prospective registry study found a greater risk for infections associated with JAK inhibitors in adolescents and adults with moderate to severe atopic dermatitis compared with biologics.

Perioral dermatitis is a skin condition characterized by a rash around the mouth. It is one type of dermatitis, which is a general term for skin irritation. In the word “perioral,” “peri ...

If you have atopic dermatitis (AD), also known as eczema, then you know the struggle: You climb into bed ready to catch some zzz's, but can't sleep because of the intense, relentless itching. Thanks ...

(dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in adults whose disease is not adequately controlled with existing therapy. In addition to COPD, Dupixent is approved in ...

In addition to COPD, Dupixent is approved in Japan in certain patients with atopic dermatitis, asthma ... More than 1,000,000 patients are being treated with Dupixent globally. 1 Dupilumab is being ...

If other common eczema treatments don't alleviate your symptoms, a dermatologist may consider dupilumab, a biologic medication ... itching and skin changes associated with neurodermatitis. Hand eczema ...

Patients receiving dupilumab vs placebo saw a significantly greater decrease in SGRQ total score and domain scores for symptoms, activity, and impacts at week 52. Dupilumab was associated with ...

ORLANDO, Fla. — In a phase 3 atopic dermatitis (AD) trial, rocatinlimab, a novel therapy that targets T cells expressing the OX40 receptor, showed efficacy on both coprimary and key secondary ...

The quality of the evidence is high. Analysis of the results of Eczema Area and Severity Index 75 in children and adolescents with moderate to severe atopic dermatitis treated with dupilumab. Eczema ...